Trial Profile
A multicenter phase Ib clinical trial of myelin oligodendrocyte glycoprotein transduced T cells in patients with insulin-dependent type 1-diabetes
Status:
Recruiting
Phase of Trial:
Phase I
Latest Information Update: 23 Aug 2017
Price :
$35
*
At a glance
- Drugs MOG transduced T cells ImCyse (Primary)
- Indications Type 1 diabetes mellitus
- Focus Adverse reactions
- 23 Aug 2017 New trial record